Search research articles
Contact Us
Filters
Showing results (1-10 of 348) with videos related to
Page
of 35
Sort By:
Research Communications in Chemical Pathology and Pharmacology
|
June 1, 1978
The effect of dobutamine on rat cardiac cyclic AMP, phosphorylase a and force of contraction
J H McNeill
Proceedings of the Western Pharmacology Society
|
January 1, 1981
Cardiac histamine and adrenergic receptors
J H McNeill
Research Communications in Chemical Pathology and Pharmacology
|
April 1, 1977
Enhancement of the cardiac phosphorylase activating effect of dibutyryl cyclic AMP by thyroid hormone
J H McNeill
Canadian Journal of Physiology and Pharmacology
|
February 1, 1970
Potentiation of norepinephrine-induced activation of cardiac phosphorylase by theopylline and reserpine
J H McNeill
Recent Advances in Studies on Cardiac Structure and Metabolism
|
May 26, 1976
Thyroid hormone-induced supersensitivity to the cardiac phosphorylase-activating effect of adrenergic amines
J H McNeill
Canadian Journal of Physiology and Pharmacology
|
January 1, 1985
1983 Upjohn Award lecture. Endocrine dysfunction and cardiac performance
J H McNeill
Diabetes Research and Clinical Practice
|
July 1, 1996
Role of elevated lipids in diabetic cardiomyopathy
J H McNeill
Canadian Journal of Physiology and Pharmacology
|
June 1, 1984
Histamine and the heart
J H McNeill
Molecular and Cellular Biochemistry
|
August 12, 2000
Vanadium and diabetes. What about vanadium toxicity?: A reply
J H McNeill
Canadian Journal of Physiology and Pharmacology
|
September 1, 1980
Histamine receptors and cyclic AMP
J H McNeill
Page
of 35
Search research articles
Search
Showing results (1-10 of 348) with videos related to
Sort By:
Page
of 35
Research Communications in Chemical Pathology and Pharmacology
|
June 1, 1978
The effect of dobutamine on rat cardiac cyclic AMP, phosphorylase a and force of contraction
J H McNeill
Proceedings of the Western Pharmacology Society
|
January 1, 1981
Cardiac histamine and adrenergic receptors
J H McNeill
Research Communications in Chemical Pathology and Pharmacology
|
April 1, 1977
Enhancement of the cardiac phosphorylase activating effect of dibutyryl cyclic AMP by thyroid hormone
J H McNeill
Canadian Journal of Physiology and Pharmacology
|
February 1, 1970
Potentiation of norepinephrine-induced activation of cardiac phosphorylase by theopylline and reserpine
J H McNeill
Recent Advances in Studies on Cardiac Structure and Metabolism
|
May 26, 1976
Thyroid hormone-induced supersensitivity to the cardiac phosphorylase-activating effect of adrenergic amines
J H McNeill
Canadian Journal of Physiology and Pharmacology
|
January 1, 1985
1983 Upjohn Award lecture. Endocrine dysfunction and cardiac performance
J H McNeill
Diabetes Research and Clinical Practice
|
July 1, 1996
Role of elevated lipids in diabetic cardiomyopathy
J H McNeill
Canadian Journal of Physiology and Pharmacology
|
June 1, 1984
Histamine and the heart
J H McNeill
Molecular and Cellular Biochemistry
|
August 12, 2000
Vanadium and diabetes. What about vanadium toxicity?: A reply
J H McNeill
Canadian Journal of Physiology and Pharmacology
|
September 1, 1980
Histamine receptors and cyclic AMP
J H McNeill
Page
of 35